MedPath

B. subtilis probiotic reduce S. aureus colonizatio

Phase 1
Completed
Registration Number
TCTR20210128003
Lead Sponsor
The Thailand Research Fund (TRF)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
683
Inclusion Criteria

None had received any antibiotic treatment or stayed at a hospital within at least three months before signing the informed-consent form for the study.

Exclusion Criteria

Currently pregnant, breastfeeding, or taking probiotic

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
the number of S. aureus in the intestine and the nose 4 week after intervention S. aureus CFU count from fece and nasal swab
Secondary Outcome Measures
NameTimeMethod
the behavior associated with S. aureus colonization after interview Questionnaires
© Copyright 2025. All Rights Reserved by MedPath